Medicare Enrolled

Dr. Isaac Levy, MD

Optician · Hollywood, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
7770 DAVIE ROAD EXT, Hollywood, FL 33024
9544501808
In practice since 2005 (20 years)
NPI: 1871577221 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Levy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Levy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Levy

Dr. Isaac Levy is an optician specialist in Hollywood, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Levy performed 858 Medicare services across 323 unique beneficiaries.

Between the years covered by Open Payments, Dr. Levy received a total of $56,793 from 90 pharmaceutical and/or device companies across 1390 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Levy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 858 Medicare services $56,793 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 47852 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
858
Medicare services
Bottom 39% in FL for optician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
323
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~43 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Blood draw (venipuncture) 275 $8 $10
Complete blood count (CBC) with differential 275 $8 $22
Office visit, established patient, complex (40-54 min) 197 $115 $250
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 78 $52 $80
New patient office visit, complex (60-74 min) 33 $175 $350
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.1% high complexity
0.0% medium
90.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$56,793
Total received (2018-2024)
Avg $8,113/year across 7 years
Top 4% in FL for optician
90
Companies
1,390
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$31,301 (55.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,434 (39.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,058 (5.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$15,269
2023
$5,901
2022
$7,992
2021
$7,365
2020
$4,395
2019
$8,870
2018
$7,001

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$14,433
GENZYME CORPORATION
$12,396
E.R. Squibb & Sons, L.L.C.
$3,412
PFIZER INC.
$3,272
Amgen Inc.
$3,056
Janssen Biotech, Inc.
$2,566
Novartis Pharmaceuticals Corporation
$1,388
Celgene Corporation
$1,068
Incyte Corporation
$1,059
Astellas Pharma US Inc
$930
Rigel Pharmaceuticals, Inc.
$870
Merck Sharp & Dohme LLC
$695
GlaxoSmithKline, LLC.
$692
BeiGene USA, Inc.
$607
Janssen Global Services, LLC
$600
Genentech USA, Inc.
$578
Merck Sharp & Dohme Corporation
$567
Eisai Inc.
$494
Seagen Inc.
$482
Lilly USA, LLC
$448
Alexion Pharmaceuticals, Inc.
$430
Exelixis Inc.
$388
Takeda Pharmaceuticals U.S.A., Inc.
$356
Bayer HealthCare Pharmaceuticals Inc.
$305
ARRAY BIOPHARMA INC
$288
Myriad Genetic Laboratories, Inc.
$257
ABBVIE INC.
$241
EISAI INC.
$236
Epizyme, Inc.,
$220
Seattle Genetics, Inc.
$219
NOVARTIS PHARMACEUTICALS CORPORATION
$208
Regeneron Healthcare Solutions, Inc.
$197
Adaptive Biotechnologies Corporation
$195
Daiichi Sankyo Inc.
$175
Taiho Oncology, Inc.
$161
Janssen Scientific Affairs, LLC
$149
Janssen Pharmaceuticals, Inc
$139
Dova Pharmaceuticals
$130
Pharmacyclics LLC, An AbbVie Company
$123
Mirati Therapeutics, Inc.
$120
AbbVie Inc.
$119
Ipsen Biopharmaceuticals, Inc
$113
Stemline Therapeutics Inc.
$111
Karyopharm Therapeutics Inc.
$111
Gilead Sciences, Inc.
$109
Medtronic, Inc.
$99
Medtronic Vascular, Inc.
$95
SOBI, INC
$93
PharmaEssentia USA Corporation
$90
Deciphera Pharmaceuticals Inc.
$90
Pharmacyclics LLC, an AbbVie Company
$83
TAIHO ONCOLOGY, INC.
$82
Bayer Healthcare Pharmaceuticals Inc.
$80
Myovant Sciences Inc.
$79
Kite Pharma, Inc.
$78
Sumitomo Pharma America, Inc.
$76
Foundation Medicine, Inc.
$74
EMD Serono, Inc.
$72
Teva Pharmaceuticals USA, Inc.
$68
TESARO, Inc.
$61
Verastem, Inc.
$57
Amneal Pharmaceuticals LLC
$54
Partner Therapeutics, Inc.
$49
Clovis Oncology, Inc.
$47
Fennec Pharmaceuticals, Inc.
$44
AbbVie, Inc.
$44
CTI BioPharma Corp.
$38
Helsinn Therapeutics (U.S.), Inc.
$38
Coherus Biosciences Inc.
$38
Blueprint Medicines Corporation
$37
MorphoSys, US Inc.
$35
GE HealthCare
$32
Kyowa Kirin, Inc.
$30
Pharmacosmos Therapeutics Inc.
$25
Epizyme, Inc.
$24
TerSera Therapeutics LLC
$22
MEDIVATION FIELD SOLUTIONS LLC
$22
Otsuka America Pharmaceutical, Inc.
$21
TG THERAPEUTICS, INC.
$19
SERVIER PHARMACEUTICALS LLC
$19
Array BioPharma Inc.
$19
SANOFI-AVENTIS U.S. LLC
$19
Sobi, Inc
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Verity Pharmaceuticals Inc.
$18
AMAG Pharmaceuticals, Inc.
$16
JAZZ PHARMACEUTICALS INC.
$16
Tempus AI, Inc
$16
SUN PHARMACEUTICAL INDUSTRIES INC.
$14
RECORDATI_RARE_DISEASES_INC.
$13
Top 3 companies account for 53.2% of total payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · AVASTIN · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CHANTIX · CYRAMZA · Cabometyx · Cerianna · Copiktra · CryoFlex · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · Enhertu · Erleada · FERAHEME · FOUNDATIONONE · FRUZAQLA · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LEUKINE · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · Lupron Depot · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · MYRISK · NIM-RESPONSE · NINLARO · Neulasta · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Odomzo · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · Pedmark · Perjeta · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · Trelstar · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYNDAQEL · Vectibix · Venclexta · Vonjo · XALKORI · XARELTO · XGEVA · XPOVIO · XT CDX · XTANDI · Xofigo · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zoladex · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (55%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 4% for optician in FL.

Equivalent to $6,619 per 100 Medicare services performed
Looking for an optician specialist in Hollywood?
Compare opticians in the Hollywood area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
835
Per 100K population
42.9
County median income
$74,534
Nearest hospital
MEMORIAL HOSPITAL PEMBROKE
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Levy is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 4% of FL peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Levy experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Levy performed 275 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Levy receive payments from pharmaceutical companies?
Yes. Dr. Levy received a total of $56,793 from 90 companies across 1,390 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Levy's costs compare to other opticians in Hollywood?
Dr. Levy's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Levy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →